What changed in Zimmer Biomet Holdings, Inc.'s latest annual report
In the year ended 31 Dec 2025, Zimmer Biomet Holdings, Inc.'s revenue rose 7.2% to USD 8.23bn, from USD 7.68bn; net income fell 22% to USD 705.10m, from USD 903.80m; long-term debt rose 29.8% to USD 6.93bn, from USD 5.34bn.
Year ended 31 Dec 2025. Source: 10-K filed 20 Feb 2026, read it on SEC EDGAR.
USD 7.68bn to USD 8.23bn
The figures, year on year
| Item | Year before | Latest year | Change |
|---|---|---|---|
| Revenue | 7.68bn | 8.23bn | Up 7.2% |
| Net income | 903.80m | 705.10m | Down 22% |
| Total assets | 21.37bn | 23.09bn | Up 8.1% |
| Total liabilities | 8.89bn | 10.39bn | Up 16.8% |
| Long-term debt | 5.34bn | 6.93bn | Up 29.8% |
| Cash and cash equivalents | 525.50m | 591.90m | Up 12.6% |
| Shareholders' equity | 12.47bn | 12.70bn | Up 1.8% |
Questions people ask
Did Zimmer Biomet Holdings, Inc.'s revenue grow last year?
Revenue grew 7.2%, from USD 7.68bn to USD 8.23bn in the year ended 31 Dec 2025.
Is Zimmer Biomet Holdings, Inc. profitable?
Yes. Net income was USD 705.10m in the year ended 31 Dec 2025. The year before: USD 903.80m.
How much cash and debt does Zimmer Biomet Holdings, Inc. have?
At its latest year end (31 Dec 2025), Zimmer Biomet Holdings, Inc. reported cash and cash equivalents of USD 591.90m and long-term debt of USD 6.93bn.
Where do these numbers come from?
From Zimmer Biomet Holdings, Inc.'s own annual filings with the SEC. Each change is calculated from the reported figures; nothing is estimated.
Meeting a client who works with Zimmer Biomet Holdings, Inc.?
LYNORIQ remembers every client meeting the way this page tracks a filing: what changed since last time, what you promised, and what they owe you.
Start free See the demoOther Orthopedic, Prosthetic & Surgical Appliances & Supplies companies
- Intuitive Surgical, Inc.Cash and cash equivalents up 66.1%
- Edwards Lifesciences CorporationNet income down 74.3%
- STERIS plcNet income up 27.3%
- Align Technology, Inc.Total liabilities down 7.5%